Vaccine currently being evaluated in Phase 3 clinical testing. Read More
Initial trial to determine if monoclonal antibodies can shorten severity of COVID-19 in outpatients. Read More
Study aims to determine safety and efficacy of experimental monoclonal antibodies. Read More
Range of new technologies will meet testing needs in diverse settings. Read More
Discovery provides new target for anti-malaria treatments. Read More
ENCODE Project's third phase offers new insights into the organization and regulation of our genes and genome. Read More
NIH-led study of mRNA vaccine supports advance to Phase 3 human trials. Read More
Scientists analyzed 40 years of data from the Framingham Heart Study. Read More
The new five-year program will leverage existing data and technologies to develop solutions for the continent’s most pressing clinical and public health problems. Read More
Multi-site trial to test candidate developed by Moderna and NIH. Read More
